Imunon, Inc. (IMNN)
1.59
-0.05
(-3.05%)
USD |
NASDAQ |
Aug 24, 16:00
1.604
+0.01
(+0.88%)
After-Hours: 20:00
Imunon EPS Diluted (Quarterly) : -0.5412 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5412 |
| March 31, 2026 | -0.8449 |
| December 31, 2025 | -1.292 |
| September 30, 2025 | -1.165 |
| June 30, 2025 | -1.866 |
| March 31, 2025 | -0.2818 |
| December 31, 2024 | -3.650 |
| September 30, 2024 | -0.3354 |
| June 30, 2024 | -0.5093 |
| March 31, 2024 | -0.5244 |
| December 31, 2023 | -0.52 |
| September 30, 2023 | -0.3708 |
| June 30, 2023 | -0.6084 |
| March 31, 2023 | -0.6752 |
| December 31, 2022 | -1.780 |
| September 30, 2022 | -0.8661 |
| June 30, 2022 | -0.8655 |
| March 31, 2022 | -1.815 |
| December 31, 2021 | -10.97 |
| September 30, 2021 | -0.9376 |
| June 30, 2021 | -0.9512 |
| March 31, 2021 | -1.287 |
| December 31, 2020 | -1.110 |
| September 30, 2020 | -3.549 |
| June 30, 2020 | -2.682 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.940 |
| December 31, 2019 | -2.001 |
| September 30, 2019 | -3.792 |
| June 30, 2019 | -4.298 |
| March 31, 2019 | -1.859 |
| December 31, 2018 | 4.365 |
| September 30, 2018 | -3.924 |
| June 30, 2018 | -6.958 |
| March 31, 2018 | -3.798 |
| December 31, 2017 | -4.064 |
| September 30, 2017 | -10.50 |
| June 30, 2017 | -11.85 |
| March 31, 2017 | -25.20 |
| December 31, 2016 | -39.90 |
| September 30, 2016 | -48.30 |
| June 30, 2016 | -39.90 |
| March 31, 2016 | -50.40 |
| December 31, 2015 | -657.39 |
| September 30, 2015 | -39.90 |
| June 30, 2015 | -56.70 |
| March 31, 2015 | -73.50 |
| December 31, 2014 | -67.20 |
| September 30, 2014 | -73.50 |
| June 30, 2014 | -79.80 |
| March 31, 2014 | -69.30 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -0.3562 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.814M |
| Total Expenses (Quarterly) | 2.814M |
| Enterprise Value | 8.399M |
| Earnings Yield | -241.7% |
| Normalized Earnings Yield | -241.87 |